industry pr

Press release news from the public relations clients of Tiziani Whitmyre, Inc.

Biosciences Newsfeed


Monday, June 1st, 2015

Symbiotix Biotherapies Announces $2.3 Million Award from NIH’s National Institute of Allergy and Infectious Diseases (NIAID)


Symbiotix logoBoston, Mass. – June 1, 2015 –
Symbiotix Biotherapies, Inc. (“Symbiotix”) today announced that it was awarded a $2.3 million Phase 2 Small Business Technology Transfer (STTR) Program award from the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID). The company, based in Boston, is developing a novel class of molecular therapeutics from the human microbiome.

Symbiotix’ lead clinical candidate, Polysaccharide A (PSA), is the first molecule to emerge from the microbiome and the $2.3 million NIH award enables the completion of key translational studies and production of material needed to take into human clinical trials as a novel treatment for multiple sclerosis (MS), said Prof. Lloyd Kasper, Professor of Medicine, Microbiology and Immunology at Geisel School of Medicine at Dartmouth College, and Co-Founder of Symbiotix.

PSA is a first-in-class oral therapy that works through a novel mechanism of action related to activation of regulatory T cells, which exert an anti-inflammatory effect through the production of IL-10.

“Current FDA-approved therapies for multiple sclerosis offer only partial benefit for reduction of relapses and time to disability. However, all of these FDA-approved treatments have side effects some of which can be rather profound,” said Prof. Kasper. “We are developing PSA as a safe and effective new oral therapy for the over 500,000 US patients with multiple sclerosis. We expect PSA to have few, if any, significant side effects as it is derived from a commensal bacterial molecule that has evolved to modulate our immune system”.

The studies funded through this prestigious award will be conducted by Symbiotix in collaboration with the Geisel School of Medicine at Dartmouth College

“Our receipt of this third NIH award enables us to move PSA towards human clinical studies as a first-in-class oral treatment for multiple sclerosis,” said Nader Yaghoubi, M.D., Ph.D., President and Chief Executive Officer of Symbiotix. “We are grateful for the continued support by NIH as we translate years of promising academic research funded by NIH into a breakthrough therapy for MS and other immune-mediated diseases”.

About Symbiotix Biotherapies, Inc.

Symbiotix Biotherapies, Inc. was founded on the basis of over a decade of research at Brigham & Women’s Hospital/Harvard Medical School, California Institute of Technology and Dartmouth College, and our Company’s scientific founders are distinguished thought leaders in the microbiome field. At Symbiotix, we are developing a novel class of molecular therapeutics based on molecules derived from the human microbiome. Our lead program represents the first molecule to emerge from the human microbiome and is a first-in-class oral agent for the treatment of serious immune-mediated diseases. For more information, please visit www.symbiotix-bio.com.


Tuesday, March 24th, 2015

AMECARE M2M Service Remotely Monitors SPECTRO ICP Spectrometers to Ensure Integrity, Avoid Downtime

SPECTRO_ARCOSKleve, Germany — March 24, 2015 — SPECTRO Analytical Instruments’ AMECARE M2M service offers the continuous remote monitoring of select SPECTRO ICP spectrometers to proactively ensure their integrity of operation and reduce the risk of downtime. The service is offered in combination with SPECTRO’s AMECARE Preventative Maintenance programs.

SPECTRO ICP spectrometers are equipped with intelligent diagnostic capabilities that report on the integrity of critical system components. With these capabilities, the cause of an instrument breakdown can be isolated and identified to speed system recovery. The technology also provides information for use with preventative intervention.

With the AMECARE M2M (Machine-to-Machine) service, diagnostic information is transmitted from the SPECTRO ICP spectrometer to SPECTRO’s central M2M server, where it is analyzed to proactively identify and flag any potential component maladjustment, degradation, or failure. If an issue is identified, the local SPECTRO service organization is alerted about the situation and the customer is contacted directly — ensuring that potential problems do not go unnoticed and are addressed proactively.

Components monitored by the M2M system include the Plasma Generator (torchbox and sample introduction system); Optical System; ICALization process; Instrument power supplies, readout and other electronic components. Benefits of the continuous monitoring include dramatically reducing the risk of instrument failure and the cost of the resulting downtime — as well as extending the life of the instrument.

User confidentially is ensured throughout the design and operation of the M2M system. The service transmits only instrument hardware and ICAL process relevant information — while analytical methods and analytical results are excluded. The system is unidirectional and secure — other than the communication handshake, information cannot be transmitted to the instrument from the remote M2M server — thus ensuring instrument encapsulation for maximum system integrity.

The AMECARE M2M intelligent diagnostic service is available on the following SPECTRO ICP spectrometers:

  • SPECTRO ARCOS FHE12 / FHS12
  • SPECTRO ARCOS 165 FHE16 / FHS16
  • SPECTRO ARCOS FHE22 / FHS22 / FHM22
  • SPECTRO ARCOS 160 FHE26 / FHS26
  • SPECTROBLUE FME16
  • SPECTROBLUE FMS16
  • SPECTROBLUE FME26
  • SPECTROBLUE FMS26
  • SPECTROBLUE FMT26
  • SPECTRO GENESIS FES17
  • SPECTRO GENESIS FEE17
  • SPECTRO MS MSS01

For more information, visit http://ow.ly/KJNoC or email spectro.info@ametek.com.

About SPECTRO:

SPECTRO, a unit of the Materials Analysis Division of AMETEK, Inc., manufactures advanced instruments, develops the best solutions for elemental analysis for a broad range of applications, and provides exemplary customer service.

SPECTRO’s products are known for their superior technical capabilities that deliver measureable benefits to the customer. From its foundation in 1979 until today, more than 30,000 analytical instruments have been delivered to customers around the world.

AMETEK, Inc. is a leading global manufacturer of electronic instruments and electromechanical products with over 15,000 colleagues at more than 120 manufacturing and sales and service operations in the United States and 30 other countries around the world.


Wednesday, March 11th, 2015

Whitepaper Details 15 Best Practices for Institutional Biosafety Committees to Improve Functionality, Compliance

Elizabeth Gilman Duane, M.S., RBP, CBSP; Practice Director, Life Sciences; Environmental Health & Engineering, Inc.

Elizabeth Gilman Duane, M.S., RBP, CBSP; Practice Director, Life Sciences; Environmental Health & Engineering, Inc.

Needham, Mass. — March 11, 2015 — Fifteen best practices to help Institutional Biosafety Committees (IBCs) improve their functionality and compliance — and better protect their workers, communities, and institutions — are detailed in a new whitepaper available to download at http://www.eheinc.com/ibc_practices.htm.

The whitepaper is titled “Best Practices for a Highly Functioning, Compliant Institutional Biosafety Committee.

“Last year there were several lapses in safety practices at Federal laboratories, drawing significant attention and compromising the public’s confidence in biomedical research,” said whitepaper author Betsy Gilman Duane, MS, RBP, CBSP, Practice Director, Life Sciences at Environmental Health & Engineering (EH&E).

“But each Institutional Biosafety Committee is unique. After satisfying the requirements of the National Institutes of Health (NIH) and their local communities, the best practices recommended in the whitepaper can enhance the experience for IBC members, facilitate compliance as well as science, and provide opportunities for improvement for Institutional Biosafety Committees as the cornerstone of their institution’s Biosafety Management System,” she stated.

The 15 best practices addressed in the whitepaper involve the scope of the Institutional Biosafety Committee, data collection, training, leadership, conflicts of interest, project and procedure reviews and audits, biosafety officer qualifications, public communications, disposition of materials, and others.

Gilman Duane is past president of the American Biological Safety Association (ABSA), facilitated the establishment of the New England Biosafety Association (NEBSA), and is on the Board of the Eagleson Institute. At EH&E, she oversees biological safety and environmental health and safety programs for life science clients.

To download the whitepaper, Best Practices for a Highly Functioning, Compliant Institutional Biosafety Committee,” visit http://www.eheinc.com/ibc_practices.htm.

 ###

About EH&E

EH&E a leading provider of environmental and engineering consulting services, guarantees that its application of science and engineering best practices will deliver measurable, quantifiable benefits in all aspects of the built environment. EH&E’s focus on evidence-based decision making and advanced capabilities in analytics and technology innovation help its clients achieve and quantify optimal performance from their people and assets. For more information, visit the EH&E website at www.eheinc.com.


Tuesday, February 10th, 2015

Brooks CSP8 Heat Sealer Processes Smaller Numbers of Tubes to Reduce Freeze-Thaw Cycles and Sample Degradation

CHELMSFORD, MASSACHUSETTS, USA, February 10, 2015 — Brooks Life Science Systems, the global leader in automated cold-chain sample management for drug discovery and biostorage applications and a division of Brooks Automation, Inc. (Nasdaq: BRKS), has introduced the CSP8 heat sealer for 96-well REMP tubes. The easy-to-use instrument permits the sealing of eight REMP tubes at a time, avoiding the need to seal an entire 96- tube rack.

The CSP8 uses Brooks’ industry-proven technology to produce tightly welded, pierceable seals. The REMP tubes’ small volumes allow for multiple aliquots of individual samples —  avoiding freeze-thaw cycles.

“The CSP8’s ability to economically seal small numbers of tubes, plus its capability to process individual aliquots, eliminates the multiple freeze-thaw cycles that lead to sample degradation,” said Christopher McNary, vice president and chief commercial officer, Brooks Life Science Systems. “Our instrument permits fast vein-to-freezer times in applications with distributed biosample collection and subsequent storage in central biobanks.”

The CSP8’s ability to seal a row of eight tubes also eliminates the cost and waste of sealing all of the tubes in a partially filled plate. In addition, the compact size of the instrument’s polyurethane seals maximizes storage density. The CSP8 heat sealer processes 0.3 ml and 0.9 ml, 96-well REMP tubes.

The CSP8 heat sealer is available for purchase from Brooks’s sales representatives. For more information, visit http://www.brooks.com/products/life-science-systems, e-mail blss.sales@brooks.com,  call 1-858-527-7000 or follow us on LinkedIn, Twitter and Facebook.

About Brooks Automation

Brooks is a leading worldwide provider of automation, vacuum, and instrumentation solutions for multiple markets including semiconductor manufacturing, life sciences, and clean energy. Our technologies, engineering competencies, and global service capabilities provide customers speed to market, and ensure high uptime and rapid response, which equate to superior value in their mission-critical controlled environments. Since 1978, we have been a leading partner to the global semiconductor manufacturing market and through product development initiatives and strategic business acquisitions; we have expanded our reach to meet the needs of customers in the life sciences industry, analytical & research markets, and clean energy solutions. Brooks is headquartered in Chelmsford, MA, with direct operations in North America, Europe, and Asia. For more information, please visit www.brooks.com.


Monday, February 9th, 2015

Brooks Introduces SampleStore(TM) II SE Sample Management System with Flexibility to Manage Multiple Consumable Types

Brooks SampleStore II SECHELMSFORD, MASSACHUSETTS, USA, February 9, 2015 — Brooks Life Science Systems, the global leader in automated cold-chain sample management for drug discovery and biostorage applications and a division of Brooks Automation, Inc. (Nasdaq: BRKS), has introduced the SampleStoreTM II SE, an extension of its SampleStore II automated storage solutions portfolio that can manage a wide range of consumable types.

“With the flexible SampleStore II SE, laboratories now can efficiently manage small to mid-size sample collections comprised of a range of tubes, vials and plates with a single automated storage solution,” said Christopher McNary, vice president and chief commercial officer, Brooks Life Science Systems. “In addition, an enhanced information management system allows the new storage solution to be used as a standalone unit or integrated with a broader enterprise IT strategy. The SampleStore II SE offers the optimal combination of flexibility and cold-chain management across a broad base of storage applications,” said McNary.

The modular SampleStore II SE solution is designed for libraries of 50,000 to 300,000 1.4 ml tubes at temperatures of -20° C to +20° C. It is scalable with expansion modules to meet future needs and can fit through a standard laboratory door.

The system’s intuitive Strata™ user interface, used across all of Brooks’ automated storage systems, makes it easy to store and retrieve samples. The Strata software also enables comprehensive sample information management, scalability, and integration with laboratory information management systems (LIMS).

“For users new to automation, the SampleStore II SE is ideal as a standalone solution for automated inventory management of chemical and biological samples,” said McNary. “Existing automated storage customers might apply the system for decentralized storage of focused or targeted chemical libraries employed in high-throughput screening (HTS) or lead optimization applications.”

The SampleStore II SE solution is part of Brooks Life Science System’s comprehensive and trusted sample management portfolio. It uses proven, highly reliable Brooks automation and refrigeration technology, and is backed by the company’s global service and technical support network.

For more information, visit http://www.brooks.com/products/life-science-systems, e-mail blss.sales@brooks.com,  call 1-858-527-7000 or follow us on LinkedIn, Twitter and Facebook

About Brooks Automation

Brooks is a leading worldwide provider of automation, vacuum, and instrumentation solutions for multiple markets including semiconductor manufacturing, life sciences, and clean energy. Our technologies, engineering competencies, and global service capabilities provide customers speed to market, and ensure high uptime and rapid response, which equate to superior value in their mission-critical controlled environments. Since 1978, we have been a leading partner to the global semiconductor manufacturing market and through product development initiatives and strategic business acquisitions; we have expanded our reach to meet the needs of customers in the life sciences industry, analytical & research markets, and clean energy solutions. Brooks is headquartered in Chelmsford, MA, with direct operations in North America, Europe, and Asia. For more information, please visit www.brooks.com.


Tuesday, December 16th, 2014

Brooks Introduces Tube Auditor 2.0 with Increased Throughput for Rapid, Non-Contact Volume Measurement of SBS-Format Microtubes

Tube AuditorCHELMSFORD, MASSACHUSETTS, USA, December 16, 2014 — Brooks Life Science Systems, the global leader in automated sample management for drug discovery and biostorage applications and a division of Brooks Automation, Inc. (Nasdaq: BRKS), has announced the introduction of the Brooks Tube AuditorTM 2.0.  Tube Auditor is a next-generation system for high-speed, non-contact sample volume and precipitate measurement of SBS-format microtubes. It dramatically increases lab productivity and helps remove uncertainty from the high-throughput screening process.

“Tube Auditor 2.0 enables rapid, non-contact sample volume measurement and precipitate detection in a single audit pass,” said Christopher McNary, vice president and chief commercial officer, Brooks Life Science Systems. “It minimizes downstream costs from the processing of empty plate wells, avoids damage to liquid-handling tips caused by failed de-cap operations, and increases confidence in the concentration of delivered output samples.

Auditing an entire 96-tube rack in approximately 90 seconds – over 13 times faster than the 20 minutes required by an automated weighing system, Tube Auditor 2.0 is compatible with nearly all SBS-format tube racks and can be used as a standalone instrument or integrated into an automated system. The instrument is exceptionally accurate — detecting sample volume changes to better than ±10μl. Tube Auditor 2.0 is ideal for compound management, high-throughput screening, and biobanking applications. It also can be used for sample quality control and empty tube and cap detection.

A case study is available that reviews how a global pharmaceutical firm employed a Tube Auditor to rapidly incorporate a sample library from an acquired company.

The Tube Auditor 2.0 is available for purchase from Brooks’s sales representatives. For more information, visit http://www.brooks.com/products/life-science-systems, e-mail blss.sales@brooks.com,  call 1-858-527-7000 or follow us on LinkedIn, Twitter and Facebook

About Brooks Automation

Brooks is a leading worldwide provider of automation, vacuum, and instrumentation solutions for multiple markets including semiconductor manufacturing, life sciences, and clean energy. Our technologies, engineering competencies, and global service capabilities provide customers speed to market, and ensure high uptime and rapid response, which equate to superior value in their mission-critical controlled environments. Since 1978, we have been a leading partner to the global semiconductor manufacturing market and through product development initiatives and strategic business acquisitions; we have expanded our reach to meet the needs of customers in the life sciences industry, analytical & research markets, and clean energy solutions. Brooks is headquartered in Chelmsford, MA, with direct operations in North America, Europe, and Asia. For more information, please visit www.brooks.com.

 


Saturday, April 26th, 2014

Parenteral Drug Association to Discuss Rapid Micro Systems and Tour Microtest Laboratories on May 6th in Agawam, Mass.

AGAWAM, MASS. — April 28, 2014 — The New England Chapter of the Parenteral Drug Association (PDA) will feature “Rapid Micro Systems: A New Tool in Navigating the Stormy Seas of Biological Testing” at a May 6 meeting in Agawam, Mass. The meeting also will include a tour of Microtest Laboratories, a leading provider of life science testing services for pharmaceutical and medical device companies.

Keynote speakers at the meeting will include the following:

Dr. Bradford O. Fanger, Ph.D., field applications scientist at Azbil BioVigilant, will discuss “Reducing Manufacturing Risk with Rapid Microbiological Methods.” In his presentation, Dr. Fanger will provide an overview of rapid microbiological systems, the different types available, and their advantages.

James Gebo, senior research and development scientist, Microtest Laboratories, will review “Evaluation and Implementation of Rapid Microbiological Methods.” His presentation will explore the applications for rapid microbiological systems, review the business case for purchasing the technology, and explain ROI reporting.

The dinner meeting will be held at Kaptain Jimmy’s Restaurant and Distillery, 916 Suffield Street, Agawam. The Microtest tour will leave the restaurant at 4 p.m. Both PDA members and non-members are invited to attend.

To register, visit https://store.pda.org/Meetings/Login.aspx?ID=2273.

About the Parenteral Drug Association

The Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 9,500 members worldwide. The New England Chapter was formed in 1988, and represents PDA members from the six New England states: Massachusetts, New Hampshire, Rhode Island, Vermont, Maine, and Connecticut.

About Microtest Laboratories

Microtest Laboratories is a leader in testing services for the medical device, pharmaceutical, and biotechnology industries. Based in Agawam, Massachusetts, USA, the company provides expertise and flexible processes that enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information, visit http://www.microtestlabs.com or call 1-413-786-1680 or toll-free 1-800-631-1680. Follow Microtest Laboratories on Facebook at http://facebook.com/MicrotestLaboratories, on LinkedIn at http://goo.gl/H8ZLnM or on Twitter @MicrotestLabs.


Tuesday, March 25th, 2014

April 9th Webinar Will Show Environmental Health and Safety (EHS) Managers How to Automate Tasks, Save Costs with Microsoft SharePoint; Presented by EH&E

Needham, Mass.— March 25, 2014 — A free April 9th webinar will show environmental health and safety managers how to streamline their EHS programs —saving costs and time — by automating key administrative tasks with Microsoft® SharePoint®, a software platform available within most companies and institutions.

EHS programs involve numerous repetitive administrative tasks — information transcription, information transfer to responsible personnel, and follow-up notifications. These consume a significant amount of valuable labor — and take away from time spent on important EHS initiatives.

By using SharePoint’s powerful workflow tools, environmental health and safety managers can automate most routine tasks related to information processing and maintaining compliance — saving countless hours and costs while improving both program efficiency and compliance.

The webinar — “SharePoint – More than Data Storage: Workflows Automate Key EHS Administrative Tasks” — will feature real-world examples to demonstrate how SharePoint workflows can be applied to:

  • Data screening and calculations — automatically flag deficiencies, calculate and compare data to pre-determined limits
  • Task notifications — send automated alerts of pending deadlines or overdue tasks
  • Approvals — automate the routing of forms and reports for review (incident reports, risk assessments, etc.)
  • Corrective Actions — manage documentation and track completion

The webinar is designed for EHS managers and directors, safety officers, biosafety officers, laboratory managers, and administrators and IT personnel. It will be held on Wednesday, April 9, 2014, from 1 p.m. to 2 p.m. Eastern Time. To register, visit http://www.eheinc.com/news_workshops/sharept_workflows_ehs.htm. There is no cost to register nor attend.

“SharePoint – More than Data Storage: Workflows Automate Key EHS Administrative Tasks” will be presented by EH&E, a leading provider of environmental and engineering consulting services. Its EHS Automation Consulting services to help companies and institutions achieve greater compliance, time and cost savings by automating their environmental health and safety programs with Microsoft SharePoint. For more information, call 1-800-825-5343 or visit www.eheinc.com/ehe_web_solutions.htm.

About EH&E

EH&E (www.eheinc.com) has provided an extensive range of environmental and engineering consulting services for 25 years. The EH&E team consists of more than 60 experts with an outstanding record of providing business-focused solutions for issues that affect the built environment. EH&E has a depth of knowledge and credibility unmatched in the industry.

Microsoft® and SharePoint® are registered trademarks of Microsoft Corporation.


Tuesday, March 11th, 2014

Webinar Exploring “What’s the Risk? Fearing the Failure in Environmental Monitoring Systems” is Offered for Life Science Companies

AGAWAM, MASS. — March 11, 2014 — A webinar to help life science companies explore the importance of a well-implemented and understood environmental monitoring program, and its ability to generate valuable data, will be offered on Wednesday, March 26, from 1:30 p.m. to 3:30 p.m. EST. The online event will identify the common mistakes and misconceptions regularly encountered when managers “fear the failure” of environmental excursions.

Environmental monitoring systems demonstrate that a company’s various contamination control strategies are operating properly. Such systems can illustrate whether operations are in a state of control. Variations in the data can indicate a drift which could potentially impact product and patient safety.

But the data generated by environmental monitoring system may become skewed when a culture is created which fears environmental failures or excursions. The webinar, What’s the Risk? Fearing the Failure in Environmental Monitoring Systems,” will detail how key life science company management can work to avoid such cultures.

Webinar topics — tailored for quality assurance and control, manufacturing, microbiology, and facilities management in pharmaceutical, biotech, and medical device organizations — will include:

  • The big picture: what systems need to be monitored and why the data is valuable
  • Risk-based environmental monitoring program implementation
  • Culture and “buy-in:” how to create a culture of employee acceptance for contamination control programs
  • Responding to data: how to identify trends in the data and respond with appropriate actions

The webinar will be offered Wednesday, March 26, 1:30 p.m. to 3:30 p.m. EST. Featured speakers include Valerie Montgomery, environmental services manager, and Alison Zulick, environmental services leader, both of Microtest Laboratories, a leading provider of testing services and contract manufacturing for the life science industries.

To register or for more information about the webinar, What’s the Risk? Fearing the Failure in Environmental Monitoring Systems,” visit http://www.microrite.com/training/environmental-monitoring-systems-fearing-the-failure.

About Microtest Laboratories

Microtest Laboratories is a leader in testing services and contract manufacturing for the medical device, pharmaceutical, and compounding pharmacy industries. Based in Agawam, Massachusetts, USA, Microtest leverages its 30 years industry experience to help its clients meet their regulatory requirements.  For more information, visit http://www.microtestlabs.com or toll-free 1-800-631-1680.

 

# # #

Press contact: Don Goncalves, 1-781-793-9380, dgoncalves@tizinc.com


Tuesday, January 21st, 2014

Brooks Introduces Next-Generation Automated Sample Storage Systems; Feature-Rich, Flexible, Reliable Technology in a Standardized Platform

Brooks SampleStoreTM II system

CHELMSFORD, MASSACHUSETTS, January 21, 2014 — Brooks Life Science Systems, a division of Brooks Automation, Inc. (Nasdaq:BRKS), has introduced its next-generation of automated systems for sample and biological storage. The systems include standardized control software that offers a best-in-class user experience. The company also launched its new “Ask Brooks” expert services portal.

The announcements were made at the Society for Lab Automation and Screening’s 2014 annual conference.

“Our next-generation automated storage systems establish new industry standards for flexibility and reliability,” said Christopher McNary, vice president and chief commercial officer, Brooks Life Science Systems. “We’ve drawn upon the best technologies developed over Brooks’ 15 years of automated storage market leadership to design a storage platform that is highly adaptable to customer needs over the lifetime of the system.”

The flexibility in Brooks’ new sample storage platform comes from its modular architecture and control software. Each system has six bays that can be populated with the industry’s widest range of modules for picking, imaging, and input/output functions. Additional sample banks can be added to the initial system via an internal bridge for future expansion. The control software offers simplified operation and installation. This versatility makes the platform easy to configure and operate, plus highly scalable to meet changing customer requirements.

“We’re leveraging Brooks’ long history in the semiconductor industry where highly reliable products have been a standard requirement for decades,” said McNary. “We incorporate this high level of reliability in our automated storage platforms to improve system uptime for the life science market.”

Built-in Dynamic Storage Optimization technology allocates storage space whenever samples are loaded, eliminating the need to predefine the mix of sample containers. High-density trays increase tube storage up to 65% in the same footprint versus 96-tube racks. A high-throughput configuration can process over 100,000 tube picks per day.

The new standardized sample storage platform consists of the following components:

  • SampleStoreTM II system: for dry powder, small molecule, and DNA samples from room temperature to -20° C with 300,000- to over 10 million-tube storage capacity
  • BioStoreTM II system: for biological sample storage to -80° C with 700,000- to 5 million-tube storage capacity
  • StrataTM automated control software: easy-to-operate and configure icon-based interface with mobile device accessibility. Simple integration with IT/LIMS systems, plus intelligent diagnostics enhances reliability.

“We’ve established a new benchmark for automated sample storage by offering the best user experience, highly flexible configuration, and ultra-reliable operation,” said McNary. “This ensures our customers can meet the changing needs of their applications – from compound storage for drug discovery to DNA, tissue, and blood serum storage for biobanking.”

The company said the first commercial systems are being installed in customer facilities and that orders can be placed immediately with Brooks’ sales representatives.

“Ask Brooks” to Provide Automated Sample Storage Expertise

Brooks also announced it has launched Ask Brooks (http://www.brooks.com/ask-brooks) as part of a new strategic advisory services offering. The Web portal will allow automated sample storage users to question Brooks’ experts about any problems or issues they are facing.

“With over 250 storage systems in place, over 1 billion samples under management, and the industry’s largest engineering staff, we are uniquely qualified to answer tough questions and solve difficult problems,” McNary said. “We encourage sample storage professionals to use the new Web portal when they face challenging applications.”

Users simply type their questions into the form on the Ask Brooks portal and Brooks’ experts will promptly respond.

About Brooks Automation

Brooks is a leading worldwide provider of automation, vacuum, and instrumentation solutions for multiple markets including semiconductor manufacturing, life sciences, and clean energy. Our technologies, engineering competencies, and global service capabilities provide customers speed to market, and ensure high uptime and rapid response, which equate to superior value in their mission-critical controlled environments. Since 1978, we have been a leading partner to the global semiconductor manufacturing market and through product development initiatives and strategic business acquisitions; we have expanded our reach to meet the needs of customers in the life sciences industry, analytical & research markets, and clean energy solutions. Brooks is headquartered in Chelmsford, MA, with direct operations in North America, Europe, and Asia. For more information, please visit www.brooks.com.


B2B News is proudly powered by WordPress.
WordPress